- Home
- KT vs VKTX Comparison
KT vs VKTX Comparison
Compare KT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KT
- VKTX
- Stock Information
- Founded
- KT 1981
- VKTX 2012
- Country
- KT South Korea
- VKTX United States
- Employees
- KT N/A
- VKTX N/A
- Industry
- KT Telecommunications Equipment
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- KT Telecommunications
- VKTX Health Care
- Exchange
- KT Nasdaq
- VKTX Nasdaq
- Market Cap
- KT 7.5B
- VKTX 7.2B
- IPO Year
- KT 1999
- VKTX 2015
- Fundamental
- Price
- KT $15.23
- VKTX $49.58
- Analyst Decision
- KT
- VKTX Strong Buy
- Analyst Count
- KT 0
- VKTX 10
- Target Price
- KT N/A
- VKTX $109.80
- AVG Volume (30 Days)
- KT 908.5K
- VKTX 6.8M
- Earning Date
- KT 11-08-2024
- VKTX 10-23-2024
- Dividend Yield
- KT 4.76%
- VKTX N/A
- EPS Growth
- KT 0.15
- VKTX N/A
- EPS
- KT 3.60
- VKTX N/A
- Revenue
- KT $20,141,620,195.00
- VKTX N/A
- Revenue This Year
- KT $2.80
- VKTX N/A
- Revenue Next Year
- KT $2.82
- VKTX N/A
- P/E Ratio
- KT $8.25
- VKTX N/A
- Revenue Growth
- KT 0.74
- VKTX N/A
- 52 Week Low
- KT $12.10
- VKTX $10.51
- 52 Week High
- KT $16.24
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- KT 45.66
- VKTX 31.07
- Support Level
- KT $14.79
- VKTX $62.50
- Resistance Level
- KT $15.86
- VKTX $70.41
- Average True Range (ATR)
- KT 0.28
- VKTX 5.16
- MACD
- KT -0.08
- VKTX -2.29
- Stochastic Oscillator
- KT 30.00
- VKTX 1.99
About KT KT Corporation
KT is South Korea's largest fixed-line telecom operator, with around 9.0 million fixed-line broadband customers and 9.4 million IPTV customers, and is the second-largest wireless operator with 25 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.